AstraZeneca Pharma inks distribution agreement with Abbott | Udaipur News | Udaipur Latest News in Hindi

AstraZeneca Pharma India and Abbott have entered into a Distribution Agreement for the distribution of Dapagliflozin, an innovative Type 2 diabetes medicine, in India. Dapagliflozin is company’s leading diabetes medicine.

Leave a Reply

Your email address will not be published. Required fields are marked *